Recent life science and diagnostic acquisitions have included Beckman Coulter, Pall, and Cepheid. In early 2020, Danaher completed the acquisition of GE Biopharma, now called Cytiva, which fills ...

Danaher Corp (DHR) reports robust cash flow and strategic acquisitions, despite facing revenue headwinds and market ...

For 2025, Danaher's 3% core revenue growth outlook ... growth than we had anticipated, including at Cepheid where it expects a decline in respiratory sales. While we still expect some adjusted ...

Cepheid's Multiplex Panel enables physicians ... talented team and strong balance sheet, all powered by the Danaher Business System, we feel well-positioned to deliver long-term shareholder ...

The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...

Hospitalizations due to the flu are the highest it’s been since 2018. Scientists don’t know why, and investors have yet to ...

Danaher CFO Matt McGrew said that the firm saw a $50 million ... The firm placed a record number of its GT450 digital pathology slide scanners in the quarter, Blair said. In Cepheid's core ...